✦ LIBER ✦

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

✍ Scribed by Guoqing Wei; Shamudheen Rafiyath; Delong Liu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line treatment of chronic myeloid

✍ Nicholas J. DiBella 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 108 KB

Dasatinib and nilotinib in first-line tr

✍ Jame Abraham 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 77 KB

Medication adherence among adults prescr

✍ Anderson, K. R.; Chambers, C. R.; Lam, N.; Yau, P. S.; Cusano, F.; Savoie, M. L. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 186 KB

Considerations for early switch to nilot

✍ Quintás-Cardama, Alfonso; Jabbour, Elias J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Different immunoprofiles in patients wit

✍ Hayashi, Yoshiki; Nakamae, Hirohisa; Katayama, Takako; Nakane, Takahiko; Koh, Hi 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 337 KB

PCN60 Cost Effectiveness of Nilotinib, D

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB